Therapeutic exploitation of IPSE, a urogenital parasite‐derived host modulatory protein, for chemotherapy‐induced hemorrhagic cystitis-Reference-Cited by-同舟云学术

Therapeutic exploitation of IPSE, a urogenital parasite‐derived host modulatory protein, for chemotherapy‐induced hemorrhagic cystitis

Published:2018-04-03 Issue:8 Volume:32 Page:4408-4419
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Mbanefo Evaristus C.¹²,Le Loc¹,Pennington Luke F.³,Odegaard Justin I.⁴,Jardetzky Theodore S.³,Alouffi Abdulaziz⁵,Falcone Franco H.⁶,Hsieh Michael H.¹²⁷

Affiliation:

1. Bladder Immunology GroupBiomedical Research InstituteRockvilleMarylandUSA

2. Division of UrologyChildren's National Medical CenterWashingtonDistrict of ColumbiaUSA

3. Department of Structural BiologyStanford University School of MedicineStanfordCaliforniaUSA

4. OneOmeRedwood CityCaliforniaUSA

5. Life Science and Environment SectorKing Abdulaziz City for Science and TechnologyRiyadhSaudi Arabia

6. Division of Molecular Therapeutics and FormulationSchool of PharmacyUniversity of NottinghamNottinghamUnited Kingdom

7. Department of UrologyThe George Washington UniversityWashingtonDistrict of ColumbiaUSA

Funder

National Institutes of Health

National Institute of Allergy and Infectious Diseases

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.201701415R

Reference76 articles.

1. Phase II Clinical Trial Results Involving Treatment with Low-Dose Daily Oral Cyclophosphamide, Weekly Vinblastine, and Rofecoxib in Patients with Advanced Solid Tumors

2. Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation

3. A retrospective study of treatment and prophylaxis of ifosfamide-induced hemorrhagic cystitis in pediatric and adolescent and young adult (AYA) patients with solid tumors

4. Hyperbaric Oxygen Treatment for Experimental Cyclophosphamide-Induced Hemorrhagic Cystitis

5. Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pattern recognition receptors and the innate immune network;Molecular Medical Microbiology;2024

2. [8] and [10]-Gingerol reduces urothelial damage in ifosfamide-induced hemorrhagic cystitis via JAK/STAT/FOXO signaling pathway via IL-10;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-02-27

3. Uroprotective effect of a protein isolated from seed ofMorinda citrifolia(McLTP₁) on hemorrhagic cystitis induced by ifosfamide in mice;2023-02-02

4. Tropisetron Ameliorated Cyclophosphamide-Induced Hemorrhagic Cystitis via Restraining TLR-4/NF-κB and JAK1/STAT3 Signaling Pathways;Archivos Españoles de Urología;2023

5. [8] and [10]-Gingerol reduces urothelial damage in ifosfamide-induced hemorrhagic cystitis via JAK/STAT/FOXO signaling pathway via IL-10;2022-11-28